Abstract: Metabolomics has become a powerful tool in chemical biology. Profiling the human sterolome has resulted in the discovery of noncanonical sterols, including oxysterols and meiosis-activating sterols. They are important to immune responses and development, and have been reviewed extensively. The triterpenoid metabolite fusidic acid has developed clinical relevance, and many steroidal metabolites from microbial sources possess varying bioactivities. Beyond the prospect of pharmacognostical agents, the profiling of minor metabolites can provide insight into an organism's biosynthesis and phylogeny, as well as inform drug discovery about infectious diseases. This review aims to highlight recent discoveries from detailed sterolomic profiling in microorganisms and their phylogenic and pharmacological implications.
Introduction
Sterols, like cholesterol 1, ergosterol 2, and sitosterol 3, as well as secondary metabolites, are amphipathic lipids that contain a 1,2-cyclopentanoperhydrophenanthrene ring nucleus ( Figure 1 ). Sterols are ubiquitous molecules found in all eukaryotic life, serving a multitude of crucial biological functions [1] . Some prokaryotes synthesize sterols as well, and some prokaryotes contain enzymes with incomplete ∆ 5 sterol biosynthesis [1] [2] [3] [4] [5] . While sterol biosynthesis may predate eukaryotes [6] , it is often hypothesized that aside from the protomitochondrial lineage, most bacteria have gained these genes via lateral gene transfer [3, 4] . The end product of ∆ 5 sterols such as cholesterol 1 and ergosterol 2 ( Figure 1a ) contribute to cell membrane fluidity in their bulk insert role in mammals and fungi, respectively [1, 7] . Steroidal secondary metabolites of the steroid hormone and bile acid classes serve well-known important roles in inflammation, sex characteristics, and lipid absorption [7] .
Minor components within the human sterol metabolome, which serve unusual but essential functions, have also been identified. For instance, the meiosis-activating sterols (MASs) 4,4-dimethylcholesta-8(9),14(15),24-trienol (follicular fluid meiosis-activating sterol; FF-MAS) 4 and 4,4-dimethylcholesta-8(9),24-dienol (testicular meiosis-activating sterol; T-MAS) 5 are biosynthetic intermediates in the cholesterol pathway that signal meiosis in mammalian oocytes and spermatozoa [7] . Various minor metabolites occurring both upstream and downstream of cholesterol have been demonstrated as ligands for nuclear hormone receptors and play critical roles in development and immunology, including 25-hydroxycholesterol 6 ( Figure 1b ) [8] [9] [10] [11] . Recent advances in methodologies in lipidomics have expedited discoveries with regard to these necessary minor human sterols and steroids, as well as provided new diagnostic screens for patients with dysregulated sterol biosynthesis, as in Niemann-Pick and Smith-Lemli-Opitz syndrome. Contemporary discoveries in human sterolomics [11] [12] [13] [14] , as well as plant sterolomics [15] , have been reviewed extensively elsewhere. Inhibitor targets of squalene epoxidase (SqE) by allylamines, e.g., terbinafine 19, sterol C14-demethylase (14-SDM = CYP51) by azoles, e.g., voriconazole 20, fluconazole 21, itraconazole 22, and posaconazole 23, sterol C14-reductase (14-SR) and sterol C8(7)-isomerase (8(7)-SI) by morpholines, e.g., fenpropimorph 24, and sterol C24-methyltransferase (24-SMT) by 25-azalanosterol 25 or 24(R,S),25-epiminolanosterol 26 are highlighted at the biosynthetic steps they block. 3-SR; sterol C3 reductase, 24-SR, sterol C24 reductase.
Novel metabolites isolated from microbial sources are conversely often found to exhibit biological activity. Famously, fusidic acid 7 (Figure 1c ), originally isolated from fungal Fusidium spp., is a tetracyclic triterpene antibacterial and has been used in the clinic for decades [27] [28] [29] . Fusidic acid inhibits growth by restricting protein synthesis via elongation factor G in Gram-positive bacteria, including Streptococcus spp., Clostridium spp., and penicillin-resistant strains of Staphylococcus spp. [28, 29] . Structural analogues of fusidic acid, have shown varying antimicrobial, as well as anticholesterolemic and antineoplastic, characteristics [29] . Isolated from a variety of fungi and sponges, as well as vascular plants, ergosterol peroxide 8 possesses broad bioactivity, including antitumor, immunomodulatory, inhibitory hemolytic, anti-inflammatory, antioxidant, and antimicrobial properties. Several other endoperoxides of other phytosterols and of cholestenols have been reported to have similar properties, as well [30] [31] [32] [33] [34] . Squalamine 9 is a non-microbially derived natural steroidal, which has demonstrated antimicrobial and antiangiogenic properties and has led to interest in synthetic analogues for structure-activity improvement [35] .
This short review aims to highlight new findings in microbial sterolomics, with respect to phylogeny, ecology, biosynthesis for drug discovery, and discovery of bioactive metabolites. Inhibitor targets of squalene epoxidase (SqE) by allylamines, e.g., terbinafine 19, sterol C14-demethylase (14-SDM = CYP51) by azoles, e.g., voriconazole 20, fluconazole 21, itraconazole 22, and posaconazole 23, sterol C14-reductase (14-SR) and sterol C8(7)-isomerase (8(7)-SI) by morpholines, e.g., fenpropimorph 24, and sterol C24-methyltransferase (24-SMT) by 25-azalanosterol 25 or 24(R,S),25-epiminolanosterol 26 are highlighted at the biosynthetic steps they block. 3-SR; sterol C3 reductase, 24-SR, sterol C24 reductase.
Figure 3.
Comparative phytosterol biosynthesis in the photosynthetic lineage from the protosterol cycloartenol 27. In algae, 24-methyl and 24-ethyl sterols arise from a bifurcation of products of biomethylation by sterol methyltransferase (SMT); In higher plants, they arise from alternate pathways from the intermediate 24 (28) -methylene lophenol 30, which can be methylated again or metabolized to campesterol 36. Red methyl groups from SMT co-substrate S-adenosyl methionine (AdoMet) are annotated to show hypothetical labeling patterns of Δ 5 sterols as discussed in [45] and [50] . An additional 15 algal sterols were reported in [45] . Truncated fungal phytosterol biosynthesis from protosterol lanosterol 12 is illustrated in Figure 2 .
The algal pathway was further corroborated by characterization of recombinant C. reinhardtii 24-SMT, found to catalyze the methylation of C24 by introduction of C28 and the methylation of C28 with C29. C. reinhardtii 24-SMT favored cycloartenol as a substrate, and a bifurcation of products to cyclolaudenol 28 and 24(28)-methylenecycloartanol 29 was found in ratios comparable to in vivo ratios of ergosterol and 7-dehydroporiferasterol [50] . A switch to Δ 25 (27) -olefin "algal" products of fungal or plant 24-SMT has been noted upon mutagenesis or incubation with electronically modified substrates [49, 51] . In addition, obtusifoliol was found to be a substrate for the second methyltransfer of C. reinhardtii 24-SMT, 24β-methyl-Δ 25 (27) -sterols were not substrates, and incubation with [methyl- Comparative phytosterol biosynthesis in the photosynthetic lineage from the protosterol cycloartenol 27. In algae, 24-methyl and 24-ethyl sterols arise from a bifurcation of products of biomethylation by sterol methyltransferase (SMT); In higher plants, they arise from alternate pathways from the intermediate 24(28)-methylene lophenol 30, which can be methylated again or metabolized to campesterol 36. Red methyl groups from SMT co-substrate S-adenosyl methionine (AdoMet) are annotated to show hypothetical labeling patterns of ∆ 5 sterols as discussed in [45, 50] . An additional 15 algal sterols were reported in [45] . Truncated fungal phytosterol biosynthesis from protosterol lanosterol 12 is illustrated in Figure 2 .
In C. reinhardtii, the biochemical pathway from the "plant" protosterol cycloartenol to the "fungal" ∆ 5 end product was investigated by sterolomic experiments of C. reinhardtii cultures. Sterol profiling of wild-type, mutant, and inhibitor-treated cultures revealed an additional 21 sterols beyond cycloartenol, ergosterol, and 7-dehydroporiferasterol 33 [45] (Figure 3 ). C. reinhardtii cultures that were not treated with a 24-SMT inhibitor contained only cycloartenol and 24-alkylsterols, indicating that bioalkylation and introduction of C28 by algal 24-SMT occurs upon cycloartenol itself early in the pathway. Further, 24-methylated cycloartenols were 24β-methylcycloart-25 (27) -enol (cyclolaudenol) 28 and 24(28)-methylenecycloartanol 29, signifying a bifurcation of methylated products of algal 24-SMT [45] . The presence of C29 (i.e., a 24-ethyl group) on a 4α,14α-dimethyl sterol 33 led to the identification of obtusifoliol 31 as the substrate for the second biomethylation reaction of the algal sterol side chain, different from the substrate preference in higher plants ( Figure 3) . Furthermore, the alkylation product in plants has a 24-ethylene substituent, whereas the product in C. reinhardtii was found to bear a 24β-ethyl group with desaturation at C25 [45] .
This pathway delineates algal biosynthesis of ergosterol disparate from the fungal pathway. In the former ∆ 25 (27) -olefin pathway, C. reinhardtii alkylates sterols at C24 in a bifurcated manner to ∆ 25 (27) -olefin and ∆ 24(28) -olefin products. ∆ 24(28) -Olefin products are further metabolized and later alkylated at C28 to only 24β-ethyl-∆ 25 (27) -olefin products. Conversely, fungal bioalkylation of C24 yields only ∆ 24(28) -olefin products, which are reduced to eventually yield ergosterol. That is, the stereochemistry of C24 in algal ergosterol arises from the methylation steps, whereas the stereochemistry of C24 in fungal ergosterol arises from a successive reduction step [45] . The ∆ 25 (27) -olefin pathway was confirmed by sterol profiling of cultures incubated with isotopically labeled [methyl-2 H 3 ]methionine ([ 2 H 3 ]Met). These algal cultures incorporated three and five deuterium atoms into ergosterol and 7-dehydroporfierasterol, respectively [45] .
The algal pathway was further corroborated by characterization of recombinant C. reinhardtii 24-SMT, found to catalyze the methylation of C24 by introduction of C28 and the methylation of C28 with C29. C. reinhardtii 24-SMT favored cycloartenol as a substrate, and a bifurcation of products to cyclolaudenol 28 and 24(28)-methylenecycloartanol 29 was found in ratios comparable to in vivo ratios of ergosterol and 7-dehydroporiferasterol [50] . A switch to ∆ 25 (27) -olefin "algal" products of fungal or plant 24-SMT has been noted upon mutagenesis or incubation with electronically modified substrates [49, 51] . In addition, obtusifoliol was found to be a substrate for the second methyltransfer of C. reinhardtii 24-SMT, 24β-methyl-∆ 25 (27) -sterols were not substrates, and incubation with [methyl-2 H 3 ]S-adenosyl methionine ( 2 H 3 -AdoMet) produced labeled products with three and five deuterium atoms [50] .
Green algae from the Acicularia spp. and Acetabularia spp. are macroscopic, yet unicellular. With a long and uninterrupted fossil record, they are often used to provide insight into the evolution of green algae and plants. ∆ 5 -Bulk sterols of these genera lack ∆ 7 desaturations, in contrast to Chlamydomonas. Trimethylsilylated (TMS) sterols extracted from Acicularia schenckii and four species of Acetabularia revealed a principal ∆ 5 sterol (60-70%) of 24-ethylcholesterol (24α/24R = sitosterol 3, 24β/24S = clionosterol 37). Four other minor ∆ 5 sterols occurred in all five species: 24-methylcholesterol (24α/24R = campesterol 36, 24β/24S = 22-dihydrobrassicasterol 38), 24-ethylcholesta-5,22E-dienol (24α/24S = stigmasterol 39, 24β/24R = poriferasterol 40), 24-methylcholesta-5,22E-dienol (24α/24S = crinosterol 41, 24β/24R = brassicasterol 42), and 24-ethylidenecholesterol, which was tentatively assigned by the authors as the ∆ 24(28)Z isomer = isofucosterol 44. Among the TMS-derivatized sterols of Acetabularia caliculus, 24-ethylcholest-7-enol 46/47 was identified ( Figure 4 , Table 1 ) [52] . Prior studies had also identified cholesterol and 24-methylenecholesterol 45 in cultures of Acetabularia mediterranea, suggested by the authors to potentially be a result of differences in algal cultivation. Acetabularia caliculus also contained 24-ethylcholesterol in the sterol ester fraction, while the other Acetabularia species and Acicularia schenckii did not contain sterols in the ester fraction. These nearly identical sets of sterols from the five species, with a large separation in their geographical origin, illustrate a lack of divergence in sterol composition. It was thus hypothesized that these sterols represent an ancient biochemical trait within the photosynthetic lineage [52] .
Molecules 2018, 23, x FOR PEER REVIEW 6 of 38 composition. It was thus hypothesized that these sterols represent an ancient biochemical trait within the photosynthetic lineage [52] . Chlorophyceae (see also 41 [55] A study investigating the sterolome via free sterols and TMS derivatives from various classes of microalgae showed two species of the green algae Chlorella, C. vulgaris and C. luteoviridis, possessing different sterol profiles [53] . C. vulgaris contained chiefly ergosterol and fungisterol 52. In the past, C. vulgaris has been reported to also contain 7-dehydroporiferasterol. The reported minor components included 5-dihydroergosterol 56, 22-dihydroergosterol 58, 24β-methylcholesta-7,25(27)-dienol 64, 24β-methylcholest-8(9)-enol 62, and lichesterol 66. Conversely, the profile of Chlorella luteoviridis was dominated by poriferasterol 40 and 22-dihydrobrassicasterol 38, with minor composition by clionasterol 35, brassicasterol, and fungisterol [53] . The predominant sterol from Nanochloropsis limnetica was cholesterol, while its minor components were isofucosterol 44, 24-ethylcholesterol (3/37), 24-methylenecholesterol 45, and clerosterol 68 [53] . This report included the sterol profiling of several species of diatoms. The diatom Stephanodiscus hantzschii, whose sterols had not been studied prior to this report, had a composition of mostly 24-methylenecholesterol, with minor components of desmosterol 48, 24-methylenelathosterol (∆ 7 , rather than ∆ 5 , termed episterol above) 17, and traces of two other sterols. Sterols from diatoms Cyclotella meneghiniana and Gomphonema parvulum were analyzed, with principal sterols of 24-methylenecholesterol and epibrassicasterol (called crinosterol, above; for list of trivial and systematic names, see Table A1 ) 41, respectively. C. meneghiniana also contained desmosterol 48, 24-methylenelathosterol, 24-dehydrolathosterol 57, and 24-ethyldesmosterol, and G. parvulum contained 5-dehydrostellasterol/ergosterol 69/2, 24α/β-ethylcholest-8(9)-enol 58/59, and campesterol/22-dihydrobrassicasterol 36/38 (C24 alkyl group was presumably α-oriented) [53] . A brief list of recently reported algal sterols by taxonomic class is presented in Figure 4 and Table 1 ; for more comprehensive and historical lists, see Refs. [47, 48] .
Trophic and Limnological Sterols
In the cross-class algal study [53] , the researchers presented these profiles, along with their quantification, as references to the algal sterolome. As prey, ∆ 7 and ∆ 7,22 sterols are often nutritionally inadequate to invertebrate consumers [53, 56, 57] . Many invertebrates are auxotrophic for sterols and rely on diet to fulfill their sterol needs for cell membrane and hormonal requirements. Several of these specimens contain alternate enzymes, which dealkylate side chains of phytosterols, yet they lack the enzymes to desaturate C5-C6 or reduce C7-C8 ( Figure 5 ) [57, 58] . It has been proposed that these quantitated algal sterolome references can be used for studies involving the nutritional content of aquatic microorganisms for aquatic invertebrates [53] . Another study monitored the sterol profiles of an algal diet and the amphipod consumer Gammarus roeselii. Prey alga N. limnetica, rich in cholesterol, and alga S. obliquus, lacking cholesterol but rich in ∆ 7 sterols (See Table 1 ), were fed to G. roeselii. The sterol profile of S. obliquus-fed G. roeselii decreased in cholesterol, and increased in the ∆ 7 metabolite lathosterol 69, detectable when the diet was 50% S. obliquus ( Figure 5 ) [56] .
Isotopically labeled sterolomic experiments have been used to explore trophic modifications by the Northern Bay scallop Argopecten irradians irradians. Dietary alga Rhodomonas was supplemented with sterols enriched with 13 C at the C22 position. The 13 C-label was noted on new sterol metabolites, including those newly desaturated with ∆ 7 and those bearing an introduced 4α-methyl group. The mollusk's ability to synthesize cholesterol from food was noted to correlate to ∆ 5 double bonds in the dietary sterols. They were more likely to dealkylate side chains possessing 24-ethyl groups. The only 24-methyl sterols dealkylated by A. irradians contained a ∆ 24 (28) olefin (i.e., 24-methylene, rather than 24-methyl) [55] . [58] .
(c) Amphipod
Gammarus roeselii can dealkylate the side chain of Δ 7 algal sterols, such as fungisterol and chondrillasterol, but cannot produce cholesterol [56] .
Isotopically labeled sterolomic experiments have been used to explore trophic modifications by the Northern Bay scallop Argopecten irradians irradians. Dietary alga Rhodomonas was supplemented with sterols enriched with 13 C at the C22 position. The 13 C-label was noted on new sterol metabolites, including those newly desaturated with Δ 7 and those bearing an introduced 4α-methyl group. The mollusk's ability to synthesize cholesterol from food was noted to correlate to Δ 5 double bonds in the dietary sterols. They were more likely to dealkylate side chains possessing 24-ethyl groups. The only 24-methyl sterols dealkylated by A. irradians contained a Δ 24 (28) olefin (i.e., 24-methylene, rather than 24-methyl) [55] .
A recent study investigated the lipid content of 37 strains within 10 classes of phytoplankton. Four classes, Cryptophyceae, Chlorophyceae, Treouciophyceae, and the diatoms are additionally represented in Table 1 ; this study additionally included dinoflagellates, euglenoids and the conjugatophyceae. Of the 37 strains, 29 sterols were detected, with notable variability of profile as a function of taxonomic class. The authors suggested Δ 5,22 sterols as a potential biomarker for Chlorophyceae Sphaerocystis sp. and ergosterol as a potential biomarker for Chlamydomonas in habitats lacking other aquatic ergosterol-synthesizing microorganisms [59] .
While sterol metabolites of toxic blooms are likely non-toxic to fish populations, these metabolites may have a stronger influence on marine invertebrates. Toxic bloom-causing algae Chloromorum toxicum, Chattonella marina, Heterosigma akashiwo, and Verrucophora farcimen [54] have sterol profiles given in Table 1 . Verrucophora sp. were found to produce the rare 27-nor sterol occelasterol 68 ( Figure 4 ) [54] . It has been proposed that isofucosterol 44 is a potential biomarker for the green-tide forming multicellular alga Ulva prolifera, and that dinosterol 74 and 24Z-propylidienecholesterol 75 are potential biomarkers for bloom-forming dinoflagellates [60] ( Figure  6 ). Toxic bloom-causing dinoflagellate Cochlodinium polykrikoides had a sterol profile including prevalent sterols of dinosterol 74 (40%), dihydrodinosterol 76 (32%), and the rare 4α-methyl sterol amphisterol 77 (23%). Small amounts of 4-methylergost-24(28)-enol 78 (5%) were detected [61] . Two isolates of the bioluminescent dinoflagellate Pyrodinium bahamense had a sterol profile of largely cholesterol (74-75%), but also components of dinosterol 74 (13-14%) and 4α-methylgorgosterol 79 [58] . (c) Amphipod Gammarus roeselii can dealkylate the side chain of ∆ 7 algal sterols, such as fungisterol and chondrillasterol, but cannot produce cholesterol [56] .
A recent study investigated the lipid content of 37 strains within 10 classes of phytoplankton. Four classes, Cryptophyceae, Chlorophyceae, Treouciophyceae, and the diatoms are additionally represented in Table 1 ; this study additionally included dinoflagellates, euglenoids and the conjugatophyceae. Of the 37 strains, 29 sterols were detected, with notable variability of profile as a function of taxonomic class. The authors suggested ∆ 5,22 sterols as a potential biomarker for Chlorophyceae Sphaerocystis sp. and ergosterol as a potential biomarker for Chlamydomonas in habitats lacking other aquatic ergosterol-synthesizing microorganisms [59] .
While sterol metabolites of toxic blooms are likely non-toxic to fish populations, these metabolites may have a stronger influence on marine invertebrates. Toxic bloom-causing algae Chloromorum toxicum, Chattonella marina, Heterosigma akashiwo, and Verrucophora farcimen [54] have sterol profiles given in Table 1 . Verrucophora sp. were found to produce the rare 27-nor sterol occelasterol 68 ( Figure 4 ) [54] . It has been proposed that isofucosterol 44 is a potential biomarker for the green-tide forming multicellular alga Ulva prolifera, and that dinosterol 74 and 24Z-propylidienecholesterol 75 are potential biomarkers for bloom-forming dinoflagellates [60] (Figure 6 ). Toxic bloom-causing dinoflagellate Cochlodinium polykrikoides had a sterol profile including prevalent sterols of dinosterol 74 (40%), dihydrodinosterol 76 (32%), and the rare 4α-methyl sterol amphisterol 77 (23%). Small amounts of 4-methylergost-24(28)-enol 78 (5%) were detected [61] . Two isolates of the bioluminescent dinoflagellate Pyrodinium bahamense had a sterol profile of largely cholesterol (74-75%), but also components of dinosterol 74 (13-14%) and 4α-methylgorgosterol 79 (11-13%), analyzed as their TMS derivatives. 4α-Methylgorgosterol is uncommon in dinoflagellates and has potential as a biomarker ( Figure 6 ) [62] .
Molecules 2018, 23, x FOR PEER REVIEW 9 of 38 (11-13%) , analyzed as their TMS derivatives. 4α-Methylgorgosterol is uncommon in dinoflagellates and has potential as a biomarker ( Figure 6 ) [62] . Lipidomic study of the coral Dendrophyllia cornigera revealed a geographical correlation to diet. D. cornigera analyzed from the Cantabrian Sea in the Northeast Atlantic reflected a productive environment, and the coral contained a high diversity of phytosterols. D. cornigera sampled from the Menorca Channel in the Mediterranean had a lower sterol content per dry weight and had less phytosterols. The Mediterranean coral had a higher relative abundance of occelasterol 70, brassicasterol 42, and cholestanol 81, or cholesterol and ergosterol, depending on the sample. The difference in the geographic profiles was attributed to a diet high in phytoplankton and herbivorous grazers in the Cantabrian coral, and a diet primarily consisting of dinoflagellates in the Mediterranean coral [63] . Specimens of the coral Agaricia spp. taken from shallow waters and deep waters were found to have markedly different sterol profiles from one another. From shallow Caribbean waters, Agaricia contained mostly cholesterol and 24-methylenecholesterol, with lower abundances of other phytosterols. Samples from deep waters contained mostly cholesterol and 24-ethylcholesterol. No gorgosterol was detected in either set. The Caribbean coral Montastraea cavernosa contained mostly 24-methylcholesterol, followed by cholesterol and gorgosterol, and variation in subsurface depth did not cause a significant change in sterol content. It was concluded that Agaricia spp. relies primarily on heterotrophy, even at greater depths [64] .
Sterolome-Informed Antimicrobial Targets

Trypanosoma brucei
Trypanosomatids are flagellated protozoa, all of which are parasitic. Some examples from this clade are Crithidia fasciculata, solely parasitic to insect hosts, Phytomonas serpens, soley phytopathogenic, and a number of human pathogens, including Trypanosoma cruzi, Leishmania spp., and Trypanosoma brucei, which are the etiological agents of the following human diseases: leishmaniasis, Chagas' disease, and human African trypanosomiasis (also known as African sleeping sickness), respectively. Most of the species, C. fasciculata [38] , P. serpens [40] , T. cruzi [38, 44] , and Leishmania spp. [39] synthesize ergosterol and other 24β-methyl/24(28)-methylene-sterols (ergostenols) de novo as their Δ 5 end products. In light of this de novo biosynthesis, there has been interest in using ergosterol biosynthesis inhibitors (EBIs) to treat Chagas' disease and leishmaniasis, and some molecules have even progressed to the clinic [25, 44] . Trypanosoma brucei, conversely, synthesizes ergostenols during its life cycle in the insect vector (procyclic form (PCF)), but uses largely cholesterol from the host's blood as its Δ 5 bulk sterol in the human host (bloodstream form (BSF)) [41] [42] [43] .
In the fly vector, cholesterol comprises a significant portion of the PCF sterol content. The profile contains sterols endogenous to PCF T. brucei, including prominent cholesta-5,7,24-trienol 82 and ergosta-5,7,25(27)-trienol 85. PCF synthesizes trace ergosterol 2; Ergosta-5,7,24(28)-trienol 85 and Lipidomic study of the coral Dendrophyllia cornigera revealed a geographical correlation to diet. D. cornigera analyzed from the Cantabrian Sea in the Northeast Atlantic reflected a productive environment, and the coral contained a high diversity of phytosterols. D. cornigera sampled from the Menorca Channel in the Mediterranean had a lower sterol content per dry weight and had less phytosterols. The Mediterranean coral had a higher relative abundance of occelasterol 70, brassicasterol 42, and cholestanol 81, or cholesterol and ergosterol, depending on the sample. The difference in the geographic profiles was attributed to a diet high in phytoplankton and herbivorous grazers in the Cantabrian coral, and a diet primarily consisting of dinoflagellates in the Mediterranean coral [63] . Specimens of the coral Agaricia spp. taken from shallow waters and deep waters were found to have markedly different sterol profiles from one another. From shallow Caribbean waters, Agaricia contained mostly cholesterol and 24-methylenecholesterol, with lower abundances of other phytosterols. Samples from deep waters contained mostly cholesterol and 24-ethylcholesterol. No gorgosterol was detected in either set. The Caribbean coral Montastraea cavernosa contained mostly 24-methylcholesterol, followed by cholesterol and gorgosterol, and variation in subsurface depth did not cause a significant change in sterol content. It was concluded that Agaricia spp. relies primarily on heterotrophy, even at greater depths [64] .
Sterolome-Informed Antimicrobial Targets
Trypanosoma brucei
Trypanosomatids are flagellated protozoa, all of which are parasitic. Some examples from this clade are Crithidia fasciculata, solely parasitic to insect hosts, Phytomonas serpens, soley phytopathogenic, and a number of human pathogens, including Trypanosoma cruzi, Leishmania spp., and Trypanosoma brucei, which are the etiological agents of the following human diseases: leishmaniasis, Chagas' disease, and human African trypanosomiasis (also known as African sleeping sickness), respectively. Most of the species, C. fasciculata [38] , P. serpens [40] , T. cruzi [38, 44] , and Leishmania spp. [39] synthesize ergosterol and other 24β-methyl/24(28)-methylene-sterols (ergostenols) de novo as their ∆ 5 end products. In light of this de novo biosynthesis, there has been interest in using ergosterol biosynthesis inhibitors (EBIs) to treat Chagas' disease and leishmaniasis, and some molecules have even progressed to the clinic [25, 44] . Trypanosoma brucei, conversely, synthesizes ergostenols during its life cycle in the insect vector (procyclic form (PCF)), but uses largely cholesterol from the host's blood as its ∆ 5 bulk sterol in the human host (bloodstream form (BSF)) [41] [42] [43] .
In the fly vector, cholesterol comprises a significant portion of the PCF sterol content. The profile contains sterols endogenous to PCF T. brucei, including prominent cholesta-5,7,24-trienol 82 and ergosta-5,7,25(27)-trienol 85. PCF synthesizes trace ergosterol 2; Ergosta-5,7,24(28)-trienol 85 and ergosta-5,7,24(25)-trienol 84 comprise some of the minor compounds present [41] [42] [43] (Figure 7 ). 24,24-Dimethylcholesta-5,7,25(27)-trienol 86 has also been detected in PCF profiles [42] .
Culturing PCF in lipid-depleted media yields a higher composition of endogenous ergostenols and cholesta-5,7,24-trienol 82 relative to cholesterol [42, 43] . Treatment of PCF cells with the 24-SMT inhibitor 25-azalanosterol 25 causes an increase in cholestenols in the profile [43] .
Sterolomic analysis of PCF revealed a novel biosynthetic network. For instance, T. brucei demethylates protosterol lanosterol 12 at C4 initially ( Figure 7 ), compared to mammalian and fungal pathways demethylating C14 first (cf. Figure 2 ) [42, 43] . Moreover, the side chain methylation patterns of 24-SMT to yield ∆ 24 (28) , ∆ 25 (27) , and ∆ 24 (25) products, as well as the ∆ 25 (27) 24,24-dimethyl product 86, are unique [42, 43, 65] . Isotopic experiments with 13 C-labeled carbon sources leucine, acetate, and glucose were shown to produce variable labeling of ∆ 5 endproducts and biosynthetic intermediates. No labelling was noted on cholesterol. Isotopic incorporation was higher with acetate and glucose. The variability of labeling was potentially attributed to the equilibrium of acetyl-CoA pools in the mitochondria and cytosol [42] . Trypanosomal sterols protothecasterol 87 (ergosta-5,7,22E,25(27)-tetraenol), cholesta-5,7,24-trienol 82, and ergosta-5,7,25(27)-trienol 83 have also been noted to incorporate isotope labeled from threonine [66] .
Molecules 2018, 23, x FOR PEER REVIEW 10 of 38 ergosta-5,7,24(25)-trienol 84 comprise some of the minor compounds present [41] [42] [43] (Figure 7 ). 24,24-Dimethylcholesta-5,7,25(27)-trienol 86 has also been detected in PCF profiles [42] . Culturing PCF in lipid-depleted media yields a higher composition of endogenous ergostenols and cholesta-5,7,24-trienol 82 relative to cholesterol [42, 43] . Treatment of PCF cells with the 24-SMT inhibitor 25-azalanosterol 25 causes an increase in cholestenols in the profile [43] . Sterolomic analysis of PCF revealed a novel biosynthetic network. For instance, T. brucei demethylates protosterol lanosterol 12 at C4 initially ( Figure 7 ), compared to mammalian and fungal pathways demethylating C14 first (cf. Figure 2 ) [42, 43] . Moreover, the side chain methylation patterns of 24-SMT to yield Δ 24 (28) , Δ 25 (27) , and Δ 24 (25) products, as well as the Δ 25 (27) 24,24-dimethyl product 86, are unique [42, 43, 65] . Isotopic experiments with 13 C-labeled carbon sources leucine, acetate, and glucose were shown to produce variable labeling of Δ 5 endproducts and biosynthetic intermediates. No labelling was noted on cholesterol. Isotopic incorporation was higher with acetate and glucose. The variability of labeling was potentially attributed to the equilibrium of acetyl-CoA pools in the mitochondria and cytosol [42] . Trypanosomal sterols protothecasterol 87 (ergosta-5,7,22E,25(27)-tetraenol), cholesta-5,7,24-trienol 82, and ergosta-5,7,25(27)-trienol 83 have also been noted to incorporate isotope labeled from threonine [66] . Figure 2 ). Values are percentage sterol composition reported by Zhou et al. [43] . Dietary cholesterol 1 accounted for 20.0 %, and other components were 16 (0.1%), 30 (1.0%), 48 (1.0%), 57 (8.0%), and others (0.2%). 24,24-Dimethylcholesta-5,7,25(27)-trienol and 86 and protothecasterol 87 were not detected in this composition, but have been reported in subsequent studies [42, 66] , respectively.
In BSF T. brucei, however, the sterol content is overwhelmingly cholesterol, as well as dietary phytosterols, like sitosterol 3 and campesterol 36, present in the hosts' blood [41] [42] [43] . Single trace 13 Clabeled sterol was found in BSF cultures fed [1-13 C]glucose [42] . Upon removal of the main sterol component cholesterol, detailed targeted sterolomics of BSF T. brucei cells revealed minor components of the sterol profile. Due to the S-cis double bond configuration in the B ring of ergosterol and compounds 81-87, UV absorbances of 282 nm can be monitored for the presence of endogenous Δ 5,7 sterols, absent in serum. Endogenous cholesta-5,7,24-trienol and ergostenols were found at trace amounts, while they were undetectable when the presence of cholesterol was predominant. The ergosterol requirements for BSF was estimated to be 0.01 fg/cell, compared to the PCF requirement of 6 fg/cell [41] . Consequently, treatment with the EBIs itraconazole 22 and 25-azalanosterol 25 resulted in parasite death and an increased survival rate of infected mice. Correspondingly, the effects of EBIs on cultures were reversed upon supplementation of ergosterol [41] . . Abbreviated biosynthetic sterol pathway and composition in T. brucei. In T. brucei, C4 is demethylated before C14, contrary to mammalian and fungal pathways (cf. Figure 2) . Values are percentage sterol composition reported by Zhou et al. [43] . Dietary cholesterol 1 accounted for 20.0 %, and other components were 16 (0.1%), 30 (1.0%), 48 (1.0%), 57 (8.0%), and others (0.2%). 24,24-Dimethylcholesta-5,7,25(27)-trienol and 86 and protothecasterol 87 were not detected in this composition, but have been reported in subsequent studies [42, 66] , respectively.
In BSF T. brucei, however, the sterol content is overwhelmingly cholesterol, as well as dietary phytosterols, like sitosterol 3 and campesterol 36, present in the hosts' blood [41] [42] [43] . Single trace 13 C-labeled sterol was found in BSF cultures fed [1-13 C]glucose [42] . Upon removal of the main sterol component cholesterol, detailed targeted sterolomics of BSF T. brucei cells revealed minor components of the sterol profile. Due to the S-cis double bond configuration in the B ring of ergosterol and compounds 81-87, UV absorbances of 282 nm can be monitored for the presence of endogenous ∆ 5,7 sterols, absent in serum. Endogenous cholesta-5,7,24-trienol and ergostenols were found at trace amounts, while they were undetectable when the presence of cholesterol was predominant. The ergosterol requirements for BSF was estimated to be 0.01 fg/cell, compared to the PCF requirement of 6 fg/cell [41] . Consequently, treatment with the EBIs itraconazole 22 and 25-azalanosterol 25 resulted in parasite death and an increased survival rate of infected mice. Correspondingly, the effects of EBIs on cultures were reversed upon supplementation of ergosterol [41] .
24-SMT substrate analogues substituted with fluorine at C26, 88 and 89 (Figure 8a ), inhibited both PCF cultures and T. brucei 24-SMT in vitro. 26-Fluorolanosterol 88 inhibited trypanosome growth with an IC 50 of about 3 µM, though it was not productively bound in T. brucei 24-SMT assays. 26-Fluorolanosterol is a reversible inhibitor of 24-SMT. Conversely, 26-fluorocholesta-5,7,24-trienol 89 is a substrate of 24-SMT, which can be turned over to 24-methylated products or bind irreversibly to the enzyme, with a k cat /k inact of 0.26 min −1 /0.24 min −1 . Sterol analysis of treated PCF revealed a loss of 24-alkylated sterols as well as a loss of 25 (27) The importance of endogenous synthesis of ergostenols in BSF is accentuated by the effectiveness of other reported EBIs [41, 43, [67] [68] [69] [70] [71] .
Acanthamoeba spp.
Ergosterol is a significant Δ 5 bulk sterol in amoebae, as is 7-dehydroporiferasterol. Sterols are synthesized de novo in amoebae via a biosynthetic pathway involving the protosterol cycloartenol 25, as in green algae and higher plants. Amoebae also synthesize 19(10→6)-abeo-sterols containing aromatic B rings called the amebasterols [22, 36] . Amebasterol-1 94, amebasterol-2 95, and amebasterol-4 98 have been described [22] ; trace amebasterols-3 96, -5 99, and -6 97 have been identified as of late ( Figure 9 ). These compounds can be selectively monitored at UV absorbances of 270 nm [36] . The sterol profile of was found to be variable as a function of growth and encystment phases. Analysis of the Acanthamoeba castellanii sterolome throughout the first week and one month after inoculation revealed a variable composition with changes to cell morphology and viability. At the beginning of the excystment-trophozoite-encystment cycle, in early log phase of growth, an accumulation of protosterol cycloartenol 27 and 24-methylenated cycloartanol 29 was noted. As the The importance of endogenous synthesis of ergostenols in BSF is accentuated by the effectiveness of other reported EBIs [41, 43, [67] [68] [69] [70] [71] .
Ergosterol is a significant ∆ 5 bulk sterol in amoebae, as is 7-dehydroporiferasterol. Sterols are synthesized de novo in amoebae via a biosynthetic pathway involving the protosterol cycloartenol 25, as in green algae and higher plants. Amoebae also synthesize 19(10→6)-abeo-sterols containing aromatic B rings called the amebasterols [22, 36] . Amebasterol-1 94, amebasterol-2 95, and amebasterol-4 98 have been described [22] ; trace amebasterols-3 96, -5 99, and -6 97 have been identified as of late ( Figure 9 ). These compounds can be selectively monitored at UV absorbances of 270 nm [36] . The importance of endogenous synthesis of ergostenols in BSF is accentuated by the effectiveness of other reported EBIs [41, 43, [67] [68] [69] [70] [71] .
Ergosterol is a significant Δ 5 bulk sterol in amoebae, as is 7-dehydroporiferasterol. Sterols are synthesized de novo in amoebae via a biosynthetic pathway involving the protosterol cycloartenol 25, as in green algae and higher plants. Amoebae also synthesize 19(10→6)-abeo-sterols containing aromatic B rings called the amebasterols [22, 36] . Amebasterol-1 94, amebasterol-2 95, and amebasterol-4 98 have been described [22] ; trace amebasterols-3 96, -5 99, and -6 97 have been identified as of late ( Figure 9 ). These compounds can be selectively monitored at UV absorbances of 270 nm [36] . The sterol profile of was found to be variable as a function of growth and encystment phases. Analysis of the Acanthamoeba castellanii sterolome throughout the first week and one month after inoculation revealed a variable composition with changes to cell morphology and viability. At the beginning of the excystment-trophozoite-encystment cycle, in early log phase of growth, an accumulation of protosterol cycloartenol 27 and 24-methylenated cycloartanol 29 was noted. As the The sterol profile of was found to be variable as a function of growth and encystment phases. Analysis of the Acanthamoeba castellanii sterolome throughout the first week and one month after inoculation revealed a variable composition with changes to cell morphology and viability. At the beginning of the excystment-trophozoite-encystment cycle, in early log phase of growth, an accumulation of protosterol cycloartenol 27 and 24-methylenated cycloartanol 29 was noted. As the cells replicated, trophozoites contained mostly the ∆ 5,7 products ergosterol and 7-dehydroporiferasterol, whereas, in the stationary growth phase, with a mixture of trophozoites and cysts, sterols shifted to the ∆ 5 products brassicasterol and poriferasterol. Supplementation of trophozoite cultures with cholesterol had only a minor stimulation effect on their growth. After one-month incubation, dead cells were mostly comprised of amebasterols, amebasterol-1 94 and amebasterol-2 95 (Figure 9 ). The shift from ∆ 5,7 products in non-viable encysted cells to the amebasterols was attributed to turnover from stress and a sterol composition associated with altered membrane fluidity affording lysis (Figure 10 ) [36] . 
Fungal Sterol Profiles in Drug-Treated Cultures
EBIs are a staple of antimycotic drug discovery [23] [24] [25] . A general hypothetical biosynthetic pathway, as well as popular block points for EBIs, are presented in Figure 2 . Sterolomics can be used to confirm the inhibition of ergosterol biosynthesis upon treatment with new small molecules with antifungal properties.
Series of amidoesters substituted with imidazolylmethyl groups were reported to have bioactivity against opportunistic fungal pathogens Candida albicans, Candida tropicalis, Cryptococcus neoformans, and Aspergillus fumigatus [77, 78] . Some of these compounds, including 100 [77] and 101 [78] (Figure 11a ) displayed better antifungal properties than fluconazole 21 (cf. Figure 2) . The sterols of C. albicans administered with these compounds were analyzed to confirm a mechanism of disrupting ergosterol biosynthesis. Ergosterol normally comprises of the vast majority of the sterol profile in C. albicans (>98%), and treatment with 100 [77] or 101 [78] reduced ergosterol in a dose dependent manner. Dose-dependent increases in lanosterol 12 were noted, as well as increases in 14α-methylsterol by-products eburicol 102 and obtusifoliol 31 (Figure 11a ). The increase in lanosterol (substrate for C. albicans 14-SDM), the increase in 14-methylsterols, and a commensurate decrease in ergosterol itself, suggested 14-SDM as a target for these molecules [77, 78] . Beyond the protosterols, ergosterol/poriferasterol pairs, brassicasterol/poriferasterol pairs, and amebasterol-1/amebasterol-2 pairs, this study identified an additional 13 minor sterols in the metabolome of A. castellanii. Labeled experiments with [ 2 H 3 ]Met elucidated labeling patterns of dideuterated ergosterol and pentadeuterated 7-dehydroporfierasterol, consistent with a ∆ 24 (28) product in its first biomethylation by SMT and a ∆ 25 (27) product in the second biomethylation (Vs. Section 2.1) [36] . Labeling outcomes are supported by in vitro mechanisms with recombinant Acanthamoebic SMTs yielding a single ∆ 24 (28) product in the first biomethylation (introduction of C28) [72] . While recombinant SMT yielded both ∆ 25 (27) and ∆ 25 (27) products for the second biomethylation (introduction of C29) [72] , the authors concluded the labeling pattern of sterols from [ 2 H 3 ]Met-fed cultures, indicating that 24(28)-ethyidene sterols are not incorporated into 7-dehydroporiferasterol under physiological conditions [36] .
The noted pairs of cycloartenol and 24(28)-methylenecycloartanol (24-H/24-Me), and pairs of ergosterol/poriferasterol, brassicasterol/poriferasterol, and amebasterol-1/amebasterol-2 (each 24-Me/24-Et) in the various portions of the Acanthamoebic life cycle [36] , along with product outcomes being largely determined by biomethylation patterns of A. castellanii SMTs [36, 72] , underscores the crucial nature of SMT function in the pathogen. Subtle alterations in substrate selectivity were noted to have a profound impact on the balance of 24-methyl and 24-ethyl sterols [36] . After treatment with the 24-SMT inhibitor 24(R,S),25-epiminolatnosterol 26 and the azole 14-SDM inhibitor voriconazole 20 (See Figure 2 for structures) , and small increase in amounts of cycloartenol and obtusifoliol were noted [72, 73] . Upon treatment with EBIs, trohpozoites were stimulated to encyst, while excystment was insensitive to treatment. The correlation between stage-specific sterol compositions and the physiological effects of EBIs provide insight on opportunities for therapeutics ( Figure 10 ). It is imagined that EBIs targeting the enzyme that reduces the ∆ 7 olefin of ergosterol/7-dehydroproferasterol to brassicasterol/poriferasterol could be used to modulate Acanthamoeba growth phases and prevent recurrence of the disease [36] .
Azole inhibitors of 14-SDM have been reported to restrict Acanthamoeba growth in the nanomolar to micromolar range [36, 37, [73] [74] [75] [76] , and inhibitors of 24-SMT have been reported with nanomolar activity against Acanthamoeba cultures [36, 72] . Treatments of 14-SDM-and 24-SMT-inhibitors in combination led to complete eradication of the amoeba parasite at concentrations as low as their respective IC 50 s [36] .
Series of amidoesters substituted with imidazolylmethyl groups were reported to have bioactivity against opportunistic fungal pathogens Candida albicans, Candida tropicalis, Cryptococcus neoformans, and Aspergillus fumigatus [77, 78] . Some of these compounds, including 100 [77] and 101 [78] (Figure 11a ) displayed better antifungal properties than fluconazole 21 (cf. Figure 2) . The sterols of C. albicans administered with these compounds were analyzed to confirm a mechanism of disrupting ergosterol biosynthesis. Ergosterol normally comprises of the vast majority of the sterol profile in C. albicans (>98%), and treatment with 100 [77] or 101 [78] reduced ergosterol in a dose dependent manner. Dose-dependent increases in lanosterol 12 were noted, as well as increases in 14α-methylsterol by-products eburicol 102 and obtusifoliol 31 (Figure 11a ). The increase in lanosterol (substrate for C. albicans 14-SDM), the increase in 14-methylsterols, and a commensurate decrease in ergosterol itself, suggested 14-SDM as a target for these molecules [77, 78] .
Many molds, like clinically relevant Mucorales, methylate the side chain of protosterol lanosterol 12, before demethylating the sterol nucleus, to produce eburicol 102 as a normal intermediate (Figure 11b ). Sterols were examined from six pathogenic molds from the order Mucorales, as well as sterols from cultures treated with the azole drug posaconazole 23 (cf. Figure 2) . The untreated molds were reported to contain ergosterol, with prominent composition by ergosta-5,7-dienol 58. An additional 12 sterols from untreated cultures were reported. Rhizopus arrhizus contained 76.3% ergosterol and 10.6% ergosta-5,7-dienol within its sterol fraction. Upon administering sub-lethal concentration of 0.5 µg/mL posaconazole 23, these percentages were reduced to 58.5% and 5.1%, respectively. Correspondingly, lanosterol and eburicol 102 increased with azole, and other 14-methylsterols were noted. Moreover, non-physiological and toxic 14-methylergosta-8,24(28)-dien-3β,6α-diol 103, which had only been found prior in azole-dosed yeasts, was detected at 0.7% in treated cells (Figure 11b ) [79] .
Of a set of sesquiterpenes isolated from Chinese liverwort Tritomaria quinquedentata (Huds.) Buch., 5 exhibited activity against strains of C. albicans. The most potent of these compounds, ent-isoalantolactone 104 suppressed hyphal formation of the yeast and was further investigated for its antifungal mechanism. An increase in lanosterol 12 and zymosterol 15 was noted in C. albicans sterol composition when applied with MIC 80 concentrations of ent-isoalantolactone (Figure 11c ). The accumulation of zymosterol connotes inhibition of Erg6p (=24-SMT). Subsequent transcriptional analysis of treated C. albicans revealed increased expression of the Erg6 gene 9.3-fold and the Erg11 (=14-SDM) gene 2.7-fold, supporting the sterolomic findings [80] . Figure 11 . Sterolomic identification of ergosterol biosynthesis inhibitors (EBIs) in fungi. Red arrows signify increase or decrease in sterols within the profile of inhibited cultures relative to non-inhibited cultures. (a) Oxazole amidoester-treated cultures of C. albicans decrease in ergosterol and increase in lanosterol and by-products obtusifoliol and eburicol, indicating disruption of 14-SDM activity [77, 78] . (b) Posaconazole-treated cultures of Rhizopus arrhizus decrease in ergosterol and ergosta-5,7-dienol and increase in lanosterol, obtusifoliol, and eburicol, and produce toxic 14-methylergosta-8,24(28)-dien-3β,6α-diol [79] . (c) ent-Isoalantolactone-treated cultures of C. albicans decrease in ergosterol and increase in lanosterol and zymosterol, indicating disruption of 24-SMT activity [80] .
Many molds, like clinically relevant Mucorales, methylate the side chain of protosterol lanosterol 12, before demethylating the sterol nucleus, to produce eburicol 102 as a normal intermediate ( Figure  11b ). Sterols were examined from six pathogenic molds from the order Mucorales, as well as sterols from cultures treated with the azole drug posaconazole 23 (cf. Figure 2) . The untreated molds were reported to contain ergosterol, with prominent composition by ergosta-5,7-dienol 58. An additional 12 sterols from untreated cultures were reported. Rhizopus arrhizus contained 76.3% ergosterol and 10.6% ergosta-5,7-dienol within its sterol fraction. Upon administering sub-lethal concentration of 0.5 µg/mL posaconazole 23, these percentages were reduced to 58.5% and 5.1%, respectively. Correspondingly, lanosterol and eburicol 102 increased with azole, and other 14-methylsterols were noted. Moreover, non-physiological and toxic 14-methylergosta-8,24(28)-dien-3β,6α-diol 103, which had only been found prior in azole-dosed yeasts, was detected at 0.7% in treated cells (Figure 11b ) [79] .
Of a set of sesquiterpenes isolated from Chinese liverwort Tritomaria quinquedentata (Huds.) Buch., 5 exhibited activity against strains of C. albicans. The most potent of these compounds, entisoalantolactone 104 suppressed hyphal formation of the yeast and was further investigated for its Figure 11 . Sterolomic identification of ergosterol biosynthesis inhibitors (EBIs) in fungi. Red arrows signify increase or decrease in sterols within the profile of inhibited cultures relative to non-inhibited cultures. (a) Oxazole amidoester-treated cultures of C. albicans decrease in ergosterol and increase in lanosterol and by-products obtusifoliol and eburicol, indicating disruption of 14-SDM activity [77, 78] . (b) Posaconazole-treated cultures of Rhizopus arrhizus decrease in ergosterol and ergosta-5,7-dienol and increase in lanosterol, obtusifoliol, and eburicol, and produce toxic 14-methylergosta-8,24(28)-dien-3β,6α-diol [79] . (c) ent-Isoalantolactone-treated cultures of C. albicans decrease in ergosterol and increase in lanosterol and zymosterol, indicating disruption of 24-SMT activity [80] .
Bioactive natural product FR171456 105 ( Figure 12 ) was shown to inhibit ergosterol biosynthesis of C. albicans, by a dose-dependent decrease in labeled zymosterol 15 and ergosterol and increase in labeled lanosterol, upon co-incubation with 13 C-glucose, 13 C-acetate. Similarly, fluconazole 21 -treated cultures also decreased in zymosterol and ergosterol [81] . Likewise, investigative drug VT-1129 106 ( Figure 12 ) caused an increase in lanosterol, eburicol, obtusifoliol, and its 3-ketone analogue, as well as reduction in ergosterol and fungisterol, in Cryptococcus sp. [82] .
Bioactive natural product FR171456 105 ( Figure 12 ) was shown to inhibit ergosterol biosynthesis of C. albicans, by a dose-dependent decrease in labeled zymosterol 15 and ergosterol and increase in labeled lanosterol, upon co-incubation with 13 C-glucose, 13 C-acetate. Similarly, fluconazole 21 -treated cultures also decreased in zymosterol and ergosterol [81] . Likewise, investigative drug VT-1129 106 ( Figure 12 ) caused an increase in lanosterol, eburicol, obtusifoliol, and its 3-ketone analogue, as well as reduction in ergosterol and fungisterol, in Cryptococcus sp. [82] . 
Bioactive Steroidal Metabolites
Endogenous oxysterols play essential roles in human biology, including signaling, development, and immunology [8] [9] [10] [11] . Similarly, several oxysterols isolated from microbial sources have been reported to exhibit therapeutic properties. Many of these compounds from microbes are oxyphytosterols, i.e., unlike human endogenous sterols, they possess alkyl groups at C24 and therefore do not occur in human biology. Bioactivities include those against cancer cell lines, as well as ligands for nuclear receptors, antioxidants, anti-inflammatory agents, and inhibitors of amyloid-β (Aβ) aggregation.
Minor steroidal metabolites often possess bioactivity against other microbes, like fusidic acid, as discussed above. Study of these natural products can further lead to semi-synthetic analogues for structure-activity relationship studies and improvement of antimicrobial agents. For instance, squalamine 9 (Figure 1c) , isolated from dogfish shark, is a steroid with polyamine substitution. The cationic polyamine moiety and its polyvalence have been attributed to much of its antimicrobial and anticancer properties [35] , and, as a result, a class of synthetic and semi-synthetic analogues, collectively termed cationic steroid antibiotics, have been developed [35, 83, 84] . For the purposes of this review, only isolated compounds are discussed, though these compounds can inform synthetic and semisynthetic analogues for increased bioactivity. Likewise, steroidal metabolites with a compromised cyclopentanoperhydrophenanthrene nucleus are omitted here.
Peroxides
Michosterol A 107 ( Figure 13 ) is a newly described polyoxygenated sterol with a C20 hydroperoxyl group and a C25 acetoxyl group, isolated by the ethyl acetate extract of the soft coral Lobophytum michaelae. Michosterol A demonstrated moderate cytotoxic effects against A549 cells, with an IC50 of 14.9 µg/mL, and was not cytotoxic (IC50s > 20 µg/mL) to DLD-1 and LNCap cell lines. Its anti-inflammatory activity was examined by assaying against superoxide formation in human neutrophils and against elastase release. Michosterol A had IC50s of 7.1 µM and 4.5 µM for superoxide anion generation and elastase release, respectively. A second hydroperoxyl polyoxygenated sterol (C15 hydroperoxyl, and Δ 17 (20) ), named michosterol B 108 ( Figure 13 ) was discovered in this extract. Michosterol B did not display cytotoxicity against the cell lines tested, but inhibited superoxide anion generation 14.7% and elastase release 31.8% each at 10 µM michosterol B [85] . 
Bioactive Steroidal Metabolites
Peroxides
Michosterol A 107 ( Figure 13 ) is a newly described polyoxygenated sterol with a C20 hydroperoxyl group and a C25 acetoxyl group, isolated by the ethyl acetate extract of the soft coral Lobophytum michaelae. Michosterol A demonstrated moderate cytotoxic effects against A549 cells, with an IC 50 of 14.9 µg/mL, and was not cytotoxic (IC 50 s > 20 µg/mL) to DLD-1 and LNCap cell lines. Its anti-inflammatory activity was examined by assaying against superoxide formation in human neutrophils and against elastase release. Michosterol A had IC 50 s of 7.1 µM and 4.5 µM for superoxide anion generation and elastase release, respectively. A second hydroperoxyl polyoxygenated sterol (C15 hydroperoxyl, and ∆ 17 (20) ), named michosterol B 108 ( Figure 13 ) was discovered in this extract. Michosterol B did not display cytotoxicity against the cell lines tested, but inhibited superoxide anion generation 14.7% and elastase release 31.8% each at 10 µM michosterol B [85] . 24-Vinyl-24-hydroperoxycholesterol 111 ( Figure 13 ) has been isolated from Xestponsgia sp. [33, 86] . It had an IC50 in an NF-κB-luciferase assay of 31.3 µg/mL [33] and restricted growth of various human cell lines, including A549 (IC50 29.0 µM) and WI-38 (IC50 43.4 µM) [86] . From Xestospongia, the 29-hydroperoxyl derivative 112 ( Figure 13 ) of isofucosterol has also been reported, with broad activity against such targets as NF-κB-luciferase (IC50 12.6 µg/mL), 3-hydroxy-3-methylglutaryl CoA reductase (HMGR)-green fluorescent protein (IC50 3.8 µg/mL) and protein tyrosine phosphatase 1B (IC50 5.8 µg/mL) [33] .
Acetates
A third michosterol, michosterol C 113 (Figure 14) , isolated from the soft coral Lobophytum michaelae (Vs. 4.1. peroxides) lacked a peroxyl moiety, but contained a 6α-acetoxyl group. Michosterol C was not cytotoxic on cell lines tested, but inhibited superoxide anion generation 17.8% at 10 µM and had an IC50 for elastase release of 0.9 µM [85] . 24-Vinyl-24-hydroperoxycholesterol 111 ( Figure 13 ) has been isolated from Xestponsgia sp. [33, 86] . It had an IC 50 in an NF-κB-luciferase assay of 31.3 µg/mL [33] and restricted growth of various human cell lines, including A549 (IC 50 29 .0 µM) and WI-38 (IC 50 43.4 µM) [86] . From Xestospongia, the 29-hydroperoxyl derivative 112 ( Figure 13 ) of isofucosterol has also been reported, with broad activity against such targets as NF-κB-luciferase (IC 50 12.6 µg/mL), 3-hydroxy-3-methylglutaryl CoA reductase (HMGR)-green fluorescent protein (IC 50 3.8 µg/mL) and protein tyrosine phosphatase 1B (IC 50 5.8 µg/mL) [33] .
A third michosterol, michosterol C 113 (Figure 14) , isolated from the soft coral Lobophytum michaelae (Vs. 4.1. peroxides) lacked a peroxyl moiety, but contained a 6α-acetoxyl group. Michosterol C was not cytotoxic on cell lines tested, but inhibited superoxide anion generation 17.8% at 10 µM and had an IC 50 for elastase release of 0.9 µM [85] .
Anicequol 114 (Figure 14) , also known as NGA0187, is a polyhydroxylated ergost-6-one first described in 2002. Originally isolated from the fungi Penicillium aurantiogriseum Dierckx TP-F0213 [87] and Acremonium sp. TF-0356 [88] , Anicequol inhibited anchorage-dependent growth of human colon cancer DLD-1 cells with an IC 50 of 1.2 µM [87] . Anicequol was found to induce anoikis, or apoptosis by loss of cell adhesion to the extracellular matrix. Induction of anoikis by anicequol, as well as 25-hydroxycholesterol, was additionally found to involve p38 mitogen-activated protein kinase (p38MAPK) and Rho-associated, coiled-coil containing kinase (ROCK), suggesting new therapeutic strategies against cancer [89] . Anicequol has neurotrophic activity and induced significant neurite outgrowth at 30 µg/mL in PC12 cells [88] . Aniceuquol has also been isolated from Aspergillus terreus (No. GX7-3B) [90] and Penicillum chrysogeum QEN-24S [91] , and supplementary activities against α-acetylcholinesterase (AchE) with an IC 50 of 1.89 µM [90] and against other fungi, with a zone of inhibition (ZOI) of cultures of the pathogen Alternaria brassicae of 6 mm compared to 16 mm by amphotericin B [91] . Anicequol 114 (Figure 14) , also known as NGA0187, is a polyhydroxylated ergost-6-one first described in 2002. Originally isolated from the fungi Penicillium aurantiogriseum Dierckx TP-F0213 [87] and Acremonium sp. TF-0356 [88] , Anicequol inhibited anchorage-dependent growth of human colon cancer DLD-1 cells with an IC50 of 1.2 µM [87] . Anicequol was found to induce anoikis, or apoptosis by loss of cell adhesion to the extracellular matrix. Induction of anoikis by anicequol, as well as 25-hydroxycholesterol, was additionally found to involve p38 mitogen-activated protein kinase (p38MAPK) and Rho-associated, coiled-coil containing kinase (ROCK), suggesting new therapeutic strategies against cancer [89] . Anicequol has neurotrophic activity and induced significant neurite outgrowth at 30 µg/mL in PC12 cells [88] . Aniceuquol has also been isolated from Aspergillus terreus (No. GX7-3B) [90] and Penicillum chrysogeum QEN-24S [91] , and supplementary activities against α-acetylcholinesterase (AchE) with an IC50 of 1.89 µM [90] and against other fungi, with a zone of inhibition (ZOI) of cultures of the pathogen Alternaria brassicae of 6 mm compared to 16 mm by amphotericin B [91] .
Penicisteroid A 115 ( Figure 14) is an analogue of anicequol bearing a 7α-hydroxyl rather than a 7-oxo-group. Extracted from Penicillium chrysogenum QEN-24S, an endophytic fungus isolated from a red alga of the genus Laurencia, penicisteroid A exhibited both antimycotic and cytotoxic effects. Against the pathogenic fungi Aspergillus niger and Alternaria brassicae, penicisteroid A gave ZOIs (20 µg) of 18 mm and 9 mm, respectively, compared to 24 mm and 16 mm for control amphotericin B. Penicisteroid A also inhibited HeLa, SW1990, and NCI-H460 cancer cell lines with IC50s of 15 µg/mL, 31 µg/mL, and 40 µg/mL, showing selectivity variable from the anicequol parent compound [91] . Penicisteroid C 116 ( Figure 14 ) also has a C16 acetate, but is less oxygenated than penicisteroid A. It was isolated from a co-cultivation of bacteria Streptomyces piomogenus AS63D and fungus Aspergillus niger using solid-state fermentation on rice medium. Penicisteroid C displayed selective antimicrobial Penicisteroid A 115 ( Figure 14) is an analogue of anicequol bearing a 7α-hydroxyl rather than a 7-oxo-group. Extracted from Penicillium chrysogenum QEN-24S, an endophytic fungus isolated from a red alga of the genus Laurencia, penicisteroid A exhibited both antimycotic and cytotoxic effects. Against the pathogenic fungi Aspergillus niger and Alternaria brassicae, penicisteroid A gave ZOIs (20 µg) of 18 mm and 9 mm, respectively, compared to 24 mm and 16 mm for control amphotericin B. Penicisteroid A also inhibited HeLa, SW1990, and NCI-H460 cancer cell lines with IC 50 s of 15 µg/mL, 31 µg/mL, and 40 µg/mL, showing selectivity variable from the anicequol parent compound [91] . Penicisteroid C 116 ( Figure 14 ) also has a C16 acetate, but is less oxygenated than penicisteroid A. It was isolated from a co-cultivation of bacteria Streptomyces piomogenus AS63D and fungus Aspergillus niger using solid-state fermentation on rice medium. Penicisteroid C displayed selective antimicrobial activity against tested organisms. ZOIs for penicisteroid C were 7 mm, 9 mm, and 10 mm for bacterial cultures Staphylococcus aureus, Bacillus cereus, and Bacillus subtilis, respectively, and were 8 mm and 12 mm for fungal cultures Candida albicans and Saccharomyces cerevisiae, respectively [92] .
A study of the oxysterols from the marine sponge Haliclona crassiloba ( Figure 14) identified two steryl acetates with antibacterial properties. Newly identified halicrasterol D 120 had minimum inhibition constants (MICs) against tested Gram-positive bacteria ranging from 4 µg/mL against Enterococcus faecalis to 128 µg/mL against S. aureus. The known diacetate compound 121, additionally isolated from H. crassiloba, had MICs ranging from 8 µg/mL against S. aureus to 32 µg/mL E. faecalis, in the bacteria tested [93] . A newly identified phytosterol acetate 122 from the soft coral Sinularia conferta exhibited low micromolar IC 50 s against cell lines PANC-1 (1.78 µM), A549 (IC 50 3.64 µM), and HeLa (19.34 µM) [94] . From Xestospongia, 25-acetoxyl sterol with an oxidized C19 (carboxylate substitution on C10), 123, was identified and exhibited an IC 50 against AMP activated protein kinase of 8.5 µg/mL [33] . Acetates 117-119 and 124-126 ( Figure 14) isolated from the coral Sacrophyton sp. inhibited Gram-positive and Gram-negative bacteria, with ZOIs ranging from 7.0-14.5 mm for Escherichia coli and from 7.5-12.0 mm for Bacillus megaterium. They also displayed antifungal properties, inhibiting Septoria tritci growth 4.5-10.5 mm [95] . Acetate 127 from the coral Nephthea erecta stimulated cytC release and inhibited Akt and mTOR phosphorylation in small cell lung cancer cells, as well as inhibiting tumor growth in the mouse xenograft model [96] . Halymeniaol 128, an triacetoxyl steroid from the rhodophyte Halymenia floresii, was recently reported to have antiplasmodial activity with an IC 50 of 3.0 µM [97] .
Cyclopropanes
From the marine sponge Xestospongia testudinaria, oxyphytosterols 129 and 130 (Figure 15) , with a side chain cyclized at C26-C27 were recently reported to posess anti-adhesion properties against bacteria Pseudoalteromonas spp. and Polaribacter sp. New compounds 129 and 133, as well as known compounds xestokerol A 130, 7α-hydroxypetrosterol 132, and aragusterol B 143 (Figure 15 ), had antifouling EC 50 s ranging from 10 to 171 µM. New compound 133 and petrosterol 135 had an EC 50 > 200 µM [98] . Some of these compounds, other known analogues, and seven new analogues have also been extracted from the marine sponge Petrosia Several oxygenated gorgostenols 150-154 (Figure 15) , isolated from the soft coral Klyxum flaccidum demonstrated selective biological activity. Compounds 150-152 and 154 were newly described and named klyflaccisteroids C-E [101] and klyflaccisteroid H [102] , respectively. These compounds demonstrated variable inhibition across human cancer cell lines, as well as inhibition of superoxide anion generation and elastase release [101, 102] . New analogues of the known trisulfate compound halistanol sulfate 155 bearing cyclopropyl rings on their side chains have been isolated from the marine sponge Halichondria sp. Halistanol sulfates I 156 and J 157 had IC 50 values for sirtuins 1-3 of 45.9, 18.9, and 32.6 µM and 67.9, 21.1, and 37.5 µM, respectively, compared to IC 50 s of the parent structure 105 of 49.1, 19.2, and 21.8 µM [103] .
Other Bioactive Steroids
Several sponge sterols, such as solomonsterol A 158 and B 159, theonellasterol 160, conicasterol 161 (Figure 16) , and their analogues, can serve as ligands for human nuclear receptors; many of these compounds and their activities have been reviewed [104] . Ganoderic acid A 163 ( Figure 16 ) and related compounds isolated from the higher fungus Ganoderma sp. possess broad therapeutic properties, including those of anti-tumor and anti-inflammation [105] . Additional recently reported bioactivities of sterols from microorganisms and algae are presented in Table 2 and Figure 16 . Table 2 . Figure 16 . Bioactive sterols and steroids. Activities are given in Table 2 .
Conclusions
Metabolomics of sterols in microorganisms have provided insight into the biology of microorganisms. Steroidal chemotaxonomy can be used to elucidate phylogenic relationships and steroidal biomarkers can be used to monitor microbial growth and biomass production. Sterolomics additionally plays an influential role in drug discovery, through validation of drug targets, by confirmation of small molecule mechanisms, and by biological testing of microbial metabolites. The sterolome of microbiota can inform chemical biology, evolutionary traits, ecology, and pharmacology. Table A1 gives the systematic names of all steroids discussed in the text. 178 ergost-24(28)-en-3β,5α,6β-triol (24-methylidenecholestan-3β,5α,6β-triol) 21775108 179 ergostan-3β,5α,6β-triol (24β-methylcholestan-3β,5α,6β-triol) 44558918 180 3β,5α,6β,11α-tetrahydroxyergostan-1-one (24β-methyl-3β,5α,6β,11α-tetrahydroxycholestan-1-one) -181 ergostan-1α,3β,5α,6β,11α-pentol (24β-methylcholestan-1α,3β,5α,6β,11α-pentol) -
182
sarcoaldesterol B ergostan-3β,5α,6β,11α-tetrol (24β-methylcholestan-3β,5α,6β,11α-tetrol) 10718409 183 ergostan-1β,3β,5α,6β-tetrol (24β-methylcholestan-1β,3β,5α,6β-tetrol) - ergostan-1α,3β,5α,6β,11α,15α-hexol (24β-methylcholestan-1α,3β,5α,6β,11α,15α-hexol) -
196
ergostan-3β,5α,6β,15α-tetrol (24β-methylcholestan-3β,5α,6β,15α-tetrol) -
197
ergostan-3β,5α,6β,11α,15α-pentol (24β-methylcholestan-3β,5α,6β,11α,15α-pentol) -198 ergost-7-en-3β,5α,6β,15α-tetrol (24β-methylcholest-7-en-3β,5α,6β,15α-tetrol) - 
